<Full-day Summary> HSI Falls by 323 Points; HSTI Declines by 84 Points; MEITUAN Drops More Than 3%; NONGFU SPRING, FOURTH PARADIGM, CHINAGOLDINTL, CONCH VENTURE, NISSIN FOODS Reach New Peaks; Market Activity Increases
Market Performance: The Hang Seng Index (HSI) fell by 323 points (1.3%) to close at 25,201, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, and HKEX saw significant drops, with Meituan down 3.1% and Tencent down 1.7%. Alibaba was an exception, gaining slightly by 0.2%.
Notable Movements: China Resources Mixc dropped sharply by 9.1%, while Nongfu Spring rose by 7.1%, reaching a new high. Other notable losers included CSPC Pharma and Hansoh Pharma.
Short Selling Activity: High short selling ratios were observed across various stocks, indicating increased bearish sentiment in the market, particularly for companies like Kuaishou and China Life.
Trade with 70% Backtested Accuracy
Analyst Views on 00241
About the author


Market Performance: The Hang Seng Index (HSI) fell by 384 points (1.4%) to close at 26,381, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 2.9% and 2.4%, respectively, with a total market turnover of $259.28 billion.
Notable Stock Movements: Major stocks like PING AN, BABA, and TENCENT saw significant declines, with PING AN dropping 4.6% and BABA down 3.6%. Conversely, HKEX and CKI Holdings were among the few gainers, with increases of 0.8% and 4.5%, respectively.
High Short Selling Activity: Several stocks experienced high short selling ratios, particularly ZHONGSHENG HLDG and BEIGENE, which saw declines of 10.8% and 9.2%, respectively, indicating bearish sentiment among investors.
Sector Highlights: The technology and healthcare sectors faced notable losses, with companies like WUXI BIO and XPENG dropping over 5%, while some stocks like FIT HON TENG showed strong gains, increasing by 11.5%.

Market Performance: The Hang Seng Index (HSI) fell by 523 points (1.9%) to 26,558, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 2.4% and 2.1%, respectively.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, and Alibaba saw significant drops, with Meituan down 4.8% and Tencent down 3.4%, amidst high short selling ratios.
Notable Declines in Constituents: Several constituents, including Hansoh Pharma and Sino Biopharma, reported steep declines, with Hansoh Pharma down 6.5% and Sino Biopharma down 6.1%.
Gainers Amidst Losses: Despite the overall market downturn, a few stocks like WH Group and Henderson Land recorded gains, with WH Group up 3.2% and Henderson Land up 1.7%, both hitting new highs.

Chinese Internet Healthcare Sector Growth: The sector is evolving with increased AI innovation from tech giants and support from national policies, such as Beijing's online consultation pilot program, despite profitability challenges.
Stock Recommendations: UOB Kay Hian maintains a positive outlook on companies like ALI HEALTH and PA GOODDOCTOR, projecting significant revenue growth driven by AI and synergies with major partners.
Top Picks in Healthcare: UOB Kay Hian's top stock picks include BEONE MEDICINES, INNOVENT BIO, and HANSOH PHARMA, highlighting their potential for growth in the Chinese healthcare market.
Investment Ratings: Various companies in the sector have received investment ratings, with several being rated as "Buy," indicating strong confidence in their future performance.

JD Health and Ali Health Performance: Both JD Health and Ali Health reported strong revenue growth last year, with pharmaceutical sales increasing by 20-30%, significantly outpacing the national market growth of only 2%.
Market Share Dynamics: The growth reflects a continuous gain in market share by online platforms over traditional hospital channels, despite a decrease in the number of physical pharmacies.
Broker Ratings and Forecasts: CLSA maintained an Outperform rating for JD Health and raised earnings forecasts, while also increasing target prices for both JD Health and Ali Health, indicating potential upside.
Valuation Insights: HSBC Global Research noted that Ali Health's current valuation has largely accounted for recent AI developments, suggesting limited room for further upside.

Market Performance: The Hang Seng Index (HSI) fell by 498 points (1.8%) to 27,469, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 1.8% and 2.1%, respectively.
Active Heavyweights: Major stocks like Xiaomi, Alibaba, and Tencent saw significant drops, with Xiaomi down 2.7%, Alibaba down 2.7%, and Tencent down 1.5%, alongside substantial short selling activity.
Notable Declines: CSPC Pharma and Zijin Mining faced sharp declines of 12.5% and 8.6%, respectively, with high short selling ratios indicating bearish market sentiment.
Gainers and New Highs: New Oriental and Huabao International were among the few gainers, with New Oriental up 3.6% and Huabao hitting a new high with a 6.2% increase.

Market Performance: The HSI rose by 598 points (2.2%) to 27,725, with significant gains in the HSCEI and HSTECH, while total market turnover reached HKD196.327 billion.
Financial Stocks Surge: Major financial stocks like HSBC, BOC Hong Kong, and Standard Chartered saw increases of 2.1% to 2.9%, contributing to a positive trend in the financial sector.
Property and Resource Stocks Rally: Hong Kong developers and Chinese developers experienced substantial gains, with some stocks like China Jinmao and Greentown China rising by over 6%, while resource stocks also saw significant increases.
Tech and AI Stocks Growth: Tech stocks such as Tencent and JD-SW gained between 1.5% and 2.4%, while AI-related stocks like SenseTime and Unisound saw notable increases, with Unisound jumping by 38.2%.





